Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Comparative Effectiveness of High-Dose Bendamustine-EAM Versus BEAM in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Erica Tsang, Diego Villa, MD, Federica Loscocco, Alina S Gerrie, MD, Giuseppe Visani, Maryse Power, MB, Barbara Guiducci, Cristina Clissa, MD PhD, Joseph M Connors, MD, Kerry J Savage, BSc, MD MSc, Kevin W Song, MD, Cindy Toze, Yasser Abou-Mourad, Heather Sutherland, MD, David Sanford, MD, Stephen H Nantel, MD, Laurie H. Sehn, MDMPH, David W. Scott, MD PhD FRACP, FRCPA, Alessandro Isidori, MD PhD

Blood (2017) 130 (Supplement 1): 3291.

https://doi.org/10.1182/blood.V130.Suppl_1.3291.3291

Published: 2017

Journal Articles

Deferasirox Boosts Hematopoietic Recovery after ALLO-Sct

Giuseppe Visani, Claudio Giardini, Federica Loscocco, Barbara Guiducci, Cristina Clissa, MD PhD, Elisa Gabucci, Alessandro Isidori, MD PhD

Blood (2017) 130 (Supplement 1): 5463.

https://doi.org/10.1182/blood.V130.Suppl_1.5463.5463

Published: 2017

Journal Articles

Benda-BEAM High-Dose Therapy Prior to Auto-SCT Is Effective in Resistant/Relapsed DLBCL

Blood (2015) 126 (23): 1999.

https://doi.org/10.1182/blood.V126.23.1999.1999

Published: 2015

Journal Articles

Low-Dose Lenalidomide Plus Low Dose Cytarabine Induce Complete Remission That Can Be Predicted By Genetic Profiling In Very Elderly Acute Myeloid Leukemia Patients

Giuseppe Visani, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Federica Loscocco, Pier Paolo Piccaluga, Fabio Fuligni, Anna Gazzola, PhD, Maura Rossi, Antonella Laginestra, Maria Rita Caraci, Cira Riccardi, Axel Visani, Sara Barulli, Barbara Guiducci, Teresa Ricciardi, Giovanni Sparaventi, Marco Rocchi, Alessandro Isidori, MD, PhD

Blood (2013) 122 (21): 496.

https://doi.org/10.1182/blood.V122.21.496.496

Published: 2013

Journal Articles

LOW-DOSE LENALIDOMIDE COUPLED with LOW-DOSE Cytarabine INDUCES COMPLETE REMISSION of Elderly ACUTE Myeloid LEUKEMIA PATIENTS with Unfavorable Citogenetics: PRELIMINARY RESULTS of A PHASE II STUDY,

Giuseppe Visani, Felicetto Ferrara, MD, Francesco Di Raimondo, MD, Maria Rita Caraci, Tiziana Izzo, Sara Barulli, Barbara Guiducci, Federica Loscocco, Teresa Ricciardi, Giovanni Sparaventi, Alessandro Isidori, MD, PhD

Blood (2011) 118 (21): 3627.

https://doi.org/10.1182/blood.V118.21.3627.3627

Published: 2011

Journal Articles

Multicentric prospective Study of Differential Treatment for Elderly Patients Affected by Aggressive Non Hodgkin Lymphoma Based On a Geriatric Multidimensional Analysis.

Guido Gini, Attilio Olivieri, MD, Caterina Bocci, Massimo Catarini, Giuseppe Visani, Mauro Montanari, M.D., Barbara Guiducci, Alessandro Isidori, MD, PhD, Marino Brunori, Francesco Alesiani, Luciano Giuliodori, Massimo Marcellini, Massimo Offidani, MD, Patrizia Caraffa, Andrea Stronati, Debora Capelli, Silvia Trappolini, Pietro Leoni

Blood (2009) 114 (22): 4775.

https://doi.org/10.1182/blood.V114.22.4775.4775

Published: 2009

Journal Articles

R-COMP 21 (Prednisone, Cyclophosphamide, Vincristine, Myocet tm and Rituximab) for Frail and Elderly Patients with Aggressive B-Cell Non-Hodgkin Lymphoma: A Pilot Study.

Alessandro Isidori, MD, Felicetto Ferrara, MD, Francesco Alesiani, MD, Sonia Ronconi, MD, Massimo Catarini, MD, Francesca D’Adamo, MD, Barbara Guiducci, MD, Daniele Bernardi, MD, Giuseppe Visani, MD

Blood (2007) 110 (11): 4442.

https://doi.org/10.1182/blood.V110.11.4442.4442

Published: 2007

NARROW

Comparative Effectiveness of High-Dose Bendamustine-EAM Versus BEAM in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Deferasirox Boosts Hematopoietic Recovery after ALLO-Sct

Benda-BEAM High-Dose Therapy Prior to Auto-SCT Is Effective in Resistant/Relapsed DLBCL

Low-Dose Lenalidomide Plus Low Dose Cytarabine Induce Complete Remission That Can Be Predicted By Genetic Profiling In Very Elderly Acute Myeloid Leukemia Patients

LOW-DOSE LENALIDOMIDE COUPLED with LOW-DOSE Cytarabine INDUCES COMPLETE REMISSION of Elderly ACUTE Myeloid LEUKEMIA PATIENTS with Unfavorable Citogenetics: PRELIMINARY RESULTS of A PHASE II STUDY,

Multicentric prospective Study of Differential Treatment for Elderly Patients Affected by Aggressive Non Hodgkin Lymphoma Based On a Geriatric Multidimensional Analysis.

R-COMP 21 (Prednisone, Cyclophosphamide, Vincristine, Myocet tm and Rituximab) for Frail and Elderly Patients with Aggressive B-Cell Non-Hodgkin Lymphoma: A Pilot Study.

Email alerts

ASH Publications

American Society of Hematology

Comparative Effectiveness of High-Dose Bendamustine-EAM Versus BEAM in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Deferasirox Boosts Hematopoietic Recovery after ALLO-Sct

Benda-BEAM High-Dose Therapy Prior to Auto-SCT Is Effective in Resistant/Relapsed DLBCL

Low-Dose Lenalidomide Plus Low Dose Cytarabine Induce Complete Remission That Can Be Predicted By Genetic Profiling In Very Elderly Acute Myeloid Leukemia Patients

LOW-DOSE LENALIDOMIDE COUPLED with LOW-DOSE Cytarabine INDUCES COMPLETE REMISSION of Elderly ACUTE Myeloid LEUKEMIA PATIENTS with Unfavorable Citogenetics: PRELIMINARY RESULTS of A PHASE II STUDY,

Multicentric prospective Study of Differential Treatment for Elderly Patients Affected by Aggressive Non Hodgkin Lymphoma Based On a Geriatric Multidimensional Analysis.

R-COMP 21 (Prednisone, Cyclophosphamide, Vincristine, Myocet tm and Rituximab) for Frail and Elderly Patients with Aggressive B-Cell Non-Hodgkin Lymphoma: A Pilot Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only